Thermo Fisher Scientific (TMO) reported quarterly earnings results on Thursday, Jul-28-2016. The company said it had a profit of $2.03 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $2.01. The company posted revenue of $4535.20 million in the period, compared to analysts expectations of $4493.28 million. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.84 EPS.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 27, 2016 to “Buy”, Firm has raised the Price Target to $ 170 from a previous price target of $166 .Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .
Thermo Fisher Scientific closed down -0.08 points or -0.05% at $158.82 with 16,45,333 shares getting traded on Thursday. Post opening the session at $157.16, the shares hit an intraday low of $156.56 and an intraday high of $159.255 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
Investors should note that on Jul 7, 2016, Thermo Fisher Scientific announced a cash dividend of $0.1500. The company’s management has announced Sep 13, 2016 as the ex-dividend date and fixed the record date on Sep 15, 2016. The payable date has been fixed on Oct 17, 2016.
In a different news, on Jul 14, 2016, Thomas W Loewald (Senior Vice President) sold 8,025 shares at $155.00 per share price. According to the SEC, on Jul 7, 2016, Marc N Casper (Chief Executive Officer) sold 20,000 shares at $147.95 per share price. On Jun 16, 2016, Daniel P Shine (Senior Vice President) sold 6,900 shares at $148.34 per share price, according to the Form-4 filing with the securities and exchange commission.
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.